Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raisuke Iijima

Showing results (51-60 of 115) with videos related to

Pageof 12
Sort By:
Cardiology|February 12, 2009
Patterns of presentation and outcomes of patients with acute coronary syndromesGjin Ndrepepa, Julinda Mehilli, Stefanie Schulz, et al.
Internal Medicine (Tokyo, Japan)|September 9, 2017
Paget-Schroetter Syndrome Resulting from Thoracic Outlet Syndrome and KAATSU TrainingTatsunori Noto, Go Hashimoto, Takahito Takagi, et al.
JACC. Cardiovascular Interventions|November 18, 2019
Endoscopy for Incomplete Endothelialization and Left Atrial Appendage Occlusion With the Watchman DeviceKeijiro Nakamura, Hidehiko Hara, Hikari Hashimoto, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 19, 2007
Stent fracture in the left brachiocephalic veinMasamichi Wada, Masaya Yamamoto, Masanori Shiba, et al.
Journal of Cardiology|August 7, 2017
Individualized antiplatelet therapy after drug-eluting stent deployment: Implication of clinical trials of different durations of dual antiplatelet therapyMasato Nakamura, Norihiro Kougame, Raisuke Iijima, et al.
BMC Cardiovascular Disorders|December 20, 2025
The impact of heart failure and bleeding risk on clinical outcomes in patients after percutaneous coronary interventionYoshiyuki Yazaki, Yoshihisa Nakagawa, Ken Kozuma, et al.
Journal of the American College of Cardiology|March 31, 2007
Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trialTom Adriaenssens, Julinda Mehilli, Rainer Wessely, et al.
American Heart Journal|April 1, 2009
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) studyRobert A Byrne, Stefanie Schulz, Julinda Mehilli, et al.
European Heart Journal|January 17, 2009
Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary interventionRaisuke Iijima, Gjin Ndrepepa, Julinda Mehilli, et al.
Circulation Reports|November 11, 2025
Relationship Between Platelet Aggregation and Clinical Events After Percutaneous Coronary Intervention for Dialysis Patients　- A PENDULUM Analysis SubstudyDaiki Yoshiura, Masanori Taniwaki, Yoshihisa Nakagawa, et al.
Pageof 12

Showing results (51-60 of 115) with videos related to

Sort By:
Pageof 12
Cardiology|February 12, 2009
Patterns of presentation and outcomes of patients with acute coronary syndromesGjin Ndrepepa, Julinda Mehilli, Stefanie Schulz, et al.
Internal Medicine (Tokyo, Japan)|September 9, 2017
Paget-Schroetter Syndrome Resulting from Thoracic Outlet Syndrome and KAATSU TrainingTatsunori Noto, Go Hashimoto, Takahito Takagi, et al.
JACC. Cardiovascular Interventions|November 18, 2019
Endoscopy for Incomplete Endothelialization and Left Atrial Appendage Occlusion With the Watchman DeviceKeijiro Nakamura, Hidehiko Hara, Hikari Hashimoto, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions|June 19, 2007
Stent fracture in the left brachiocephalic veinMasamichi Wada, Masaya Yamamoto, Masanori Shiba, et al.
Journal of Cardiology|August 7, 2017
Individualized antiplatelet therapy after drug-eluting stent deployment: Implication of clinical trials of different durations of dual antiplatelet therapyMasato Nakamura, Norihiro Kougame, Raisuke Iijima, et al.
BMC Cardiovascular Disorders|December 20, 2025
The impact of heart failure and bleeding risk on clinical outcomes in patients after percutaneous coronary interventionYoshiyuki Yazaki, Yoshihisa Nakagawa, Ken Kozuma, et al.
Journal of the American College of Cardiology|March 31, 2007
Does addition of estradiol improve the efficacy of a rapamycin-eluting stent? Results of the ISAR-PEACE randomized trialTom Adriaenssens, Julinda Mehilli, Rainer Wessely, et al.
American Heart Journal|April 1, 2009
Rationale and design of a randomized, double-blind, placebo-controlled trial of 6 versus 12 months clopidogrel therapy after implantation of a drug-eluting stent: The Intracoronary Stenting and Antithrombotic Regimen: Safety And EFficacy of 6 Months Dual Antiplatelet Therapy After Drug-Eluting Stenting (ISAR-SAFE) studyRobert A Byrne, Stefanie Schulz, Julinda Mehilli, et al.
European Heart Journal|January 17, 2009
Profile of bleeding and ischaemic complications with bivalirudin and unfractionated heparin after percutaneous coronary interventionRaisuke Iijima, Gjin Ndrepepa, Julinda Mehilli, et al.
Circulation Reports|November 11, 2025
Relationship Between Platelet Aggregation and Clinical Events After Percutaneous Coronary Intervention for Dialysis Patients　- A PENDULUM Analysis SubstudyDaiki Yoshiura, Masanori Taniwaki, Yoshihisa Nakagawa, et al.
Pageof 12